Managing Bone Health After Menopause: What Patients Should Know

Managing Bone Health After Menopause: What Patients Should Know

August 11, 2026

Ever wonder why bone health becomes an issue after menopause and what can be done to lower the risk of bone loss? Hormone changes after menopause can play a role in reduction of bone density and women should consult their health care provider regarding bone health. Doctors may suggest lifestyle changes, supplements, monitoring, and/or prescription treatment, depending on your risk factors. 

Onco Health Mart offers information and specialty medicine to patients and caregivers. Prolia 60mg Injection is prescribed to women with osteoporosis at high risk of fracture as part of a medically-supervised treatment program. So what should patients know before initiating treatment and bone health maintenance for the long run?
 

Why Bone Health Matters After Menopause 

Bone is an active tissue that's constantly broken down and rebuilt. In women, low or decreased levels of estrogen after menopause may lead to greater bone loss. This can cause a decrease in bone mineral density and increase risk of osteoporosis and fractures over time.

But all women are not at the same risk. There are factors that can affect bone health, such as age, family history of fractures, previous fractures, body weight, physical activity, smoking, alcohol abuse, some medical conditions and some medicines.

These factors, as well as bone mineral density testing, may be assessed by a health care professional to decide if treatment is needed.
 

Understanding Prolia 60mg Injection 

Prolia 60mg Injection is a RANK ligand inhibitor that treats postmenopausal osteoporosis in women who are at high risk for fracture. It is injected under the skin by a health care provider, and the recommended dose for osteoporosis is 60 mg every six months.

The treatment should only be used according to a doctor's prescription. Patients should talk to their health care provider prior to taking the medication about their medical history, medicines they are taking, and any medical or calcium or kidney-related concerns.

Low calcium levels can occur during treatment with denosumab and any existing hypocalcemia should be treated before starting denosumab therapy. Depending on the patient's needs, the doctor may prescribe calcium and vitamin D supplementation.
 

Lifestyle Steps That Support Stronger Bones 

Medication is just one aspect of long-term care of bone health. There are other preventable risk factors and ways to keep the bones strong that can be adopted through the routine.

Patients should talk to their health care provider about the following:

  1. Moderate amounts of weight-bearing and muscle strengthening exercise suitable for their health and fitness.
  2. Calcium and Vitamin D as prescribed by medical doctors and/or personal dietary requirements.
  3. Not smoking and drinking too much alcohol.
  4. Making modifications to minimize the risk of falling at home and during activities.
  5. Scheduling recommended bone density test(s) and follow-up visits.
     

It is also important to get a proper balance of calcium, protein and other nutrients in your diet, which can help maintain your body's musculoskeletal balance.
 

Monitoring During Osteoporosis Treatment 

Treatment of osteoporosis using medication should be accompanied by regular medical follow-up. Your doctor may check the calcium level as well as your overall response to treatment. Severe hypocalcemia can occur in patients with advanced chronic kidney disease and these patients may be at increased risk and patient monitoring is important.

Patients should also perform good oral hygiene, and, if they are planning to have dental work done, inform their healthcare provider about this. Dental health may be important before and during denosumab therapy, as there have been reports of osteonecrosis of the jaw.

Treatment continuity is another key factor to consider. Withholding, omitting or delaying denosumab administration may increase the risk for patients to develop vertebral fractures. Patients should thus consult their physician about any treatment changes or quitting treatment without physician supervision.
 

Capsy 500mg tablet 

Capsy 500mg tablet contains capecitabine and is a prescription medicine used in some cancer treatment centres, such as those treating breast, colon and rectal cancer. It is not a medicine for osteoporosis, and should not be used as an alternative to denosumab.

Dosage and treatment regimen of Capsy 500mg tablet will vary depending on the condition treated and the doctor's prescription. It must only be taken as directed by the doctor and the patient should tell their health care provider about any medicines they are taking.

Never use a generic medicine in place of a prescription medicine, as different medicines are used to treat various conditions.
 

Adenoz Injection 

Adenoz injection is a medicine that slows down the speed of the heart (anti-arrhythmic) used in certain situations with abnormal heart rhythms (tachycardia) including paroxysmal supraventricular tachycardia. It is given in a health care facility by a health care professional only and is not a treatment for osteoporosis.

If a patient is taking more than one therapy, he or she should give the physician a full account of the medications used. This is very critical if they are cared for by different experts.
 

When Should You Discuss Bone Treatment? 

As women get older, they can talk with a healthcare provider about their personal fracture risk, particularly if they have a fracture or other osteoporosis risk factors.

Once they have diagnosed osteoporosis, they might take into account different factors before deciding on treatment. These may include bone mineral density, fracture history, age, other health conditions, kidney function, calcium levels and current medications.

Onco Health Mart may be able to provide information about specialty medicines: treatment decisions must be made by the qualified healthcare professional responsible for the patient's treatment.
 

Conclusion

Taking care of bone health post-menopause is not just about one medicine. Moderate exercise, proper diet, avoiding falls, and compliance with treatment can be integrated into a management plan. The use of Prolia 60mg Injection for post-menopausal women at high risk for fracture due to osteoporosis has not been established by a health care professional and should be used with caution.

Onco Health Mart offers patients and caregivers information and assistance related to specialty medicine. For information about a prescribed medicine, please contact us in mid and speak with the appropriate healthcare professional. You can also check out our Google My Business profile for more information on our business and services offered.